Allied Market Research published a report, titled, Post-Traumatic Stress Disorder Treatment Market by Treatment Type (Drugs, Pyschotherapy), By Age Group (Pediartic, Geriatric, Adult), By End User (Hospitals, Outpaitent Clinics, Mental Health Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.‘ According to the report, the global post-traumatic stress disorder treatment industry was estimated at $16.0 billion in 2021, and is anticipated to hit $26.1 billion by 2031, registering a CAGR of 4.9% from 2022 to 2031.

Post-traumatic stress disorder (PTSD) is a mental health condition triggered by either experiencing it or witnessing it. Post-traumatic stress disorder treatment help to improve in patient’s thinking power, changes in physical activity & regains a sense of control over life. The mode of treatment applied for post-traumatic stress disorder includes medication, therapies, self-care & nutrition.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/12965

Key players in the industry-

  • Behavioral Health Network, Inc.
  • CareTech Holdings Plc
  • GlaxoSmithKline Plc
  • Viatris, Inc
  • North Range Behavioral Health
  • Strategic Behavioral Health
  • Pyramid Healthcare
  • Pfizer, Inc
  • Eily Lilly and Company
  • Acadia Healthcare
  • Ascension Seton

Key Market Segments

  • By Treatment Type
    • Drugs
    • Pyschotherapy
  • By Age Group
    • Pediartic
    • Geriatric
    • Adult
  • By End User
    • Mental Health Center
    • Others
    • Hospitals
    • Outpaitent Clinics

Specific Requirement on COVID-19? Ask to Our Industry Expert:
https://www.alliedmarketresearch.com/request-for-customization/12965?reqfor=covid

Leave a comment

Your email address will not be published. Required fields are marked *